MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE Amex:OPK), today announced that in connection with the completion of its previously announced underwritten public offering of 27,000,000 shares of common stock, the Company completed, pursuant to the over-allotment option exercised by the underwriters, a public offering of an additional 2,397,029 shares of its common stock, at a price of $3.75 per share, before underwriting discounts and commissions. All of the shares were offered by the Company. The Company received approximately $8.5 million in net proceeds from the offering after underwriting fees.
